RSS

HGENQ Humanigen Inc.

Mod: drfreak1

Last Post: 07/15/24

Followers: 2

Posts Today: 0

Views Today: 11

HGENQ Stock Quote & Tools

Company Profile Buy Rating Time & Sales News Filings Financials

HGENQ Stock Message Board Discussion

New Post Follow

znewcar1 02/06/2023 1:22:16 PM

$HGEN hod.2289 S
znewcar1 01/30/2023 2:48:15 PM

HGEN hod.17 [email protected]? or les and my how much?
znewcar1 01/27/2023 2:28:09 PM

#V2.3M battle .15 RLL.0924 MH.195 w/30dma
(1)
znewcar1 01/27/2023 11:45:37 AM

EYE yet if lod.1484 bd
(1)
SaltyMutt 01/27/2023 6:32:57 AM

I'm thinking that HGEN moves above .165 today.
znewcar1 01/04/2023 4:07:10 PM

$HGEN 41% v12,3M c.17 f119,080M H.195 ML.0924
znewcar1 12/30/2022 4:48:25 PM

$HGEN 26% v5,8M c.12 f119,080M H.125 ML.0924
whytestocks 11/14/2022 4:11:58 PM

$HGEN News Article - Humanigen Reports Third Quarter 2022 Financial Results
znewcar1 11/01/2022 10:01:01 PM

$HGEN 19% v4,4M c.168 f103M H.168 ML.135
whytestocks 10/31/2022 10:10:50 AM

$HGEN News Article - Humanigen Announces Retention of SC&H Capital as Financial Advisor
whytestocks 09/28/2022 2:50:56 PM

$HGEN News Article - DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff
whytestocks 09/07/2022 8:06:23 AM

$HGEN News Article - Humanigen to Participate in H.C. Wainwright and Cantor Investor Conferences in
znewcar1 07/08/2022 4:39:29 PM

HGEN 28% v12,0M c2.99 f70,6M H3.25 ML1.61
whytestocks 07/06/2022 8:21:02 AM

$HGEN News Article - Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early
whytestocks 06/03/2022 10:30:51 AM

$HGEN News Article - Humanigen Announces Participation and Presentation at Multiple Conferences in
znewcar1 03/06/2022 11:47:17 PM

HGEN 6% v2,8M c2.48 f65,3M ML1.67 H2.76
whytestocks 10/26/2021 12:15:50 PM

$HGEN News Article - First Patient Dosed in Phase 2 Precision Medicine Study of Lenzilumab in
whytestocks 10/25/2021 10:50:51 AM

$HGEN News Article - European Commission Selects Humanigen's Lenzilumab as One of the 10 Most
whytestocks 10/19/2021 2:35:59 PM

$HGEN News Article - Humanigen Announces Late-Breaking Presentation at the CHEST Annual Meeting
whytestocks 10/08/2021 8:20:53 AM

$HGEN News Article - Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program
whytestocks 09/29/2021 11:20:52 AM

$HGEN News Article - Humanigen Announces Oral Presentation of Lenzilumab LIVE-AIR Phase 3 Study
(1)
whytestocks 06/07/2021 2:45:50 PM

$HGEN News Article - Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor
whytestocks 04/30/2021 4:10:48 PM

$HGEN News Article - 3 Popular Reddit Biotech Stocks That You Should Avoid
whytestocks 04/09/2021 1:50:50 PM

$HGEN News Article - Humanigen Announces Positive Results From Phase 1 Study of Ifabotuzumab in
znewcar1 03/29/2021 10:30:40 PM

HGEN 54% v89M c21.61 f53M H29.2 S21.2
whytestocks 03/29/2021 1:40:47 PM

$HGEN News Article - Why Humanigen Stock Is Skyrocketing Today
whytestocks 03/29/2021 12:40:47 PM

$HGEN News Article - Cruise Stocks: Why RCL, CCL and NCLH Stocks Are Sinking Today
whytestocks 03/29/2021 12:00:48 PM

$HGEN News Article - HGEN Stock: Why Covid-19 Play Humanigen Is Skyrocketing 100% Today
whytestocks 03/29/2021 10:15:48 AM

$HGEN News Article - Humanigen Reports Positive Phase 3 Topline Results Demonstrating That
whytestocks 01/22/2021 10:20:48 AM

$HGEN News Article - Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S.
znewcar1 12/21/2020 4:42:22 PM

HGEN 27% v2,72M c19.85 f51,6M H20.15 S18.3
znewcar1 12/17/2020 5:43:55 PM

HGEN 23% v2,5M c14.04 f51,6M H14.36 S13.7
whytestocks 12/17/2020 10:55:48 AM

$HGEN News Article - Humanigen to Present at J.P. Morgan Healthcare Conference
whytestocks 12/17/2020 10:50:48 AM

$HGEN News Article - Humanigen Announces Completion of Enrollment in Phase 1 Study of Ifabotuzumab
znewcar1 12/14/2020 5:25:35 PM

HGEN 26% v1,3M c11.96 f51,6M H12.22 eod push to HH strong aft
EmergingGrowth 11/30/2020 9:28:00 AM

HGEN
whytestocks 11/06/2020 10:55:47 AM

$HGEN News Article - Humanigen Announces Cooperative Research and Development Agreement with the
whytestocks 10/29/2020 8:25:47 AM

$HGEN News Article - Humanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial
whytestocks 10/02/2020 10:45:49 AM

$HGEN News Article - Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution and
whytestocks 10/02/2020 10:25:45 AM

$HGEN News Article - Humanigen Announces Lenzilumab in COVID-19 Program Updates
whytestocks 09/14/2020 8:00:47 AM

$HGEN News Article - Humanigen Announces Review of Lenzilumab Phase 3 Study in COVID-19 by Data
whytestocks 08/24/2020 3:00:46 PM

$HGEN News Article - Humanigen Appoints Edward P. Jordan as Chief Commercial Officer
whytestocks 08/03/2020 8:55:46 AM

$HGEN News Article - Humanigen to Host Investor Conference Call to Discuss NIH's Selection of
whytestocks 07/27/2020 4:25:46 PM

$HGEN News Article - National Institutes of Health Selects Humanigen's Lenzilumab for its COVID-19
whytestocks 07/16/2020 11:20:50 AM

$HGEN News Article - Humanigen Expands Partnership with Catalent Biologics to Manufacture
whytestocks 06/30/2020 8:05:52 AM

$HGEN News Article - First Patient Infused in Joint Humanigen/Kite, A Gilead Company Clinical Study
znewcar1 06/02/2020 4:03:11 PM

HGEN 126% v2,42M c2.54 f126,3M H2.848 S2.45
whytestocks 06/03/2019 8:10:41 AM

$HGEN News Article - Humanigen to Present at the Jefferies 2019 Healthcare Conference
whytestocks 05/31/2019 2:40:40 PM

$HGEN News Article - Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational
whytestocks 05/31/2019 2:35:41 PM

$HGEN News Article - Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational